BOT 5.00% 38.0¢ botanix pharmaceuticals ltd

Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-199

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,079 Posts.
    lightbulb Created with Sketch. 269
    I just hope now that we see a clear seperation in the derma study, like we have in the Australian arm.

    Frankly i think they are clutching at straws explaining the vehicle manufacturing process as the problem... I think they stuffed the trial but dont want to admit it as it may stop them proceeding to phase 3.

    What a big shame. Would have been a stellar result otherwise
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.